Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Home
  • News
  • Articles
  • Exclusive
  • HB Originals
  • Gallery
  • Advertisement
Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Medical Science
Search
  • Home
  • Categories
    • Medical Science
    • Health Awareness
  • Bookmarks
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
© 2025 Health Hub Media Pvt Ltd. All Rights Reserved.
Healthcare Leadership, Policy & Digital Health News India > Blog > News > CDSCO Launches Digital Monitoring System on ONDLS to Track High-Risk Solvents

CDSCO Launches Digital Monitoring System on ONDLS to Track High-Risk Solvents

Published: October 25, 2025
SHARE

India’s drug regulator, CDSCO, has rolled out a real-time digital system on the ONDLS portal to monitor the supply and quality of high-risk solvents used in pharmaceutical manufacturing a move triggered by recent cough syrup contamination incidents.

Glimpse:

In response to fatal cases of syrup contamination, CDSCO has upgraded the Online National Drug Licensing System (ONDLS) to track high-risk solvents (like glycerin, propylene glycol, sorbitol, PEG, et al.). Manufacturers must now register, upload batch-level data and Certificates of Analysis (CoA), and submit vendor information giving regulators full visibility over production and distribution.

Amid growing alarm over cough syrups tainted with diethylene glycol (DEG), India’s Central Drugs Standard Control Organisation (CDSCO) has launched a digital monitoring system via the ONDLS portal to strengthen oversight of high-risk solvents used in pharmaceutical manufacturing

All state and union territory drug controllers have been instructed to ensure that manufacturers of pharmaceutical-grade solvents including glycerin, propylene glycol, maltitol, sorbitol, polyethylene glycol, and others obtain proper licensing via ONDLS. Existing licensees must register under the system’s “Old Licence Management” section and submit detailed records such as batch quantities, vendor information, and Certificates of Analysis (CoA).

Under the new mandate, no batch of these solvents can be released or distributed without proper registration, testing, and regulatory approval. The system enables real-time tracking of supply chains and quality assurance, closing loopholes in transparency and accountability across manufacturing and distribution.

This measure is part of CDSCO’s response to the shock caused by multiple child deaths in Madhya Pradesh, where contaminated cough syrup (notably “Coldrif”) was found to contain DEG far above permissible limits. The digital monitoring push reflects an urgency to prevent further pharmaceutical safety failures.

“We must ensure that the building blocks of medicines are beyond reproach this digital system gives us the eyes to detect, trace and prevent contamination.”

By

HB Team

Related News

Graviti Pharma Expands South India Footprint with Strategic Karnataka Entry

April 24, 2026

India–UK Biotech Corridor Launched to Power Next Wave of Life Sciences Innovation

April 23, 2026

Premji Invest Backs Newera Hospitals to Expand Advanced Care Beyond Metro Cities

April 23, 2026

Eli Lilly Strikes $7B Deal to Supercharge Next Gen Cancer Therapies

April 22, 2026

Venkaiah Naidu Unveils Atal MedTech Museum to Showcase India’s Healthcare Innovation Journey

April 23, 2026

Boehringer Ingelheim Launches £150M AI Hub in London to Accelerate Drug Discovery

April 23, 2026

Kotak Mahindra Bank Backs Advanced Diagnostics Upgrade at Mumbai’s Somaiya Hospital

April 23, 2026

Odisha Approves ₹3,877 Cr Investments to Accelerate Pharma and MedTech Growth

April 23, 2026

Siemens Healthineers Explores Karnataka Partnership to Build Future Ready HealthTech Hubs

April 18, 2026

Eli Lilly Eyes Kelonia Buyout to Accelerate Next Gen Cancer Therapies

April 20, 2026

Anlon Healthcare Acquires Remember India Health Links to Enter Formulations Market

April 17, 2026

Aurobindo’s Theranym Biologics to Invest Up to $175M in New Biologics Manufacturing Facility

April 17, 2026

GSK Completes $950M 35Pharma Acquisition to Strengthen Biologics and Cardiopulmonary Pipeline

April 16, 2026

Maharashtra FDA Proposes ₹500 Crore Plan to Modernise Drug Testing Labs and Strengthen Regulatory Framework

April 16, 2026

NIPER Mohali Signs Pact with Novartis to Boost Pharmaceutical Research and Innovation in India

April 16, 2026

Biocon Appoints Mandar Ghatnekar as Chief Technology Officer to Accelerate Digital and AI Transformation

April 10, 2026

Serum Institute and Trivitron Gear Up for Major Push into Global Diagnostics via MyLab JV

April 7, 2026

Serum Institute in Advanced Talks with Trivitron to Take MyLab Discovery Global via New Joint Venture

April 7, 2026

Alkem Laboratories Doubles Investment to ₹1,036 Crore for New Greenfield Formulations Facility in Ujjain

April 4, 2026

UPSIDA Signs MoU with JNPA to Transform Lalitpur Pharma Park into Global Export Hub

April 6, 2026
GIMS-CMI Hospital Incubator Backs MedTech Startup That Raises $2M Seed Round
FBI Seizes Hacktivist Websites Following Major Cyberattack on Stryker
National AI Policy for Healthcare Under Preparation, Reveals NHA CEO
Verily Launches Verily Me! AI-Powered App for Seamless Medical Data & Personalized Health
Symplr Rolls Out AI-Driven Tools to Optimize Healthcare Operations at ViVE 2026
Your browser does not support the audio element.
Your browser does not support the audio element.

Contact us

Privacy Policy

Terms & Conditions

HealthBuzz is a leading platform for healthcare news in India, covering hospital leadership updates, health policy developments, digital health innovations, and emerging healthcare startups. Stay informed with the latest insights shaping India’s healthcare ecosystem.

Facebook Twitter Youtube Whatsapp

Quick Links

  • Home
  • Articles
  • HB Originals
  • News
  • Videos
  • Gallery

Company

  • About us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Content Complaince

Install our Mobile App for Best Experience

Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
Follow US
Health Hub Media Pvt. Ltd. © 2026 All Rights Reserved
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?